• Ep. 254 - Takeaways from Grand Rounds 2024

  • Sep 20 2024
  • Length: 35 mins
  • Podcast

Ep. 254 - Takeaways from Grand Rounds 2024

  • Summary

  • On a special edition of the BioCentury This Week podcast, BioCentury’s editors deliver their takeaways from the debut Grand Rounds conference, which focused on whether biotech can write a more successful playbook for translating from target to product. Weaving together takeaways from the panels, fireside chat and keynote at the conference, the editors assess the tensions between generalizability and fit-for-purpose models, between having control and capturing complexity, and, in human data, between scale and robustness/reliability, particularly for longitudinal readouts. The editors also discuss BioCentury's Q&A with USC Keck School’s Patrick Lyden, who explained how high-quality, reproducible preclinical science can be feasible.

    View full story: https://www.biocentury.com/article/653631

    00:00 - Introduction
    02:56 - Generalizability vs. Fit for Purpose
    10:03 - Control vs. Complexity
    17:57 - Scale vs. Robustness in Human Data
    26:25 - Hypothesis-Driven vs. Unbiased Research
    28:50 - Grand Rounds 2025


    To submit a question to BioCentury’s editors, email the BioCentury This Week team at podcasts@biocentury.com.

    Reach us by sending a text

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Ep. 254 - Takeaways from Grand Rounds 2024

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.